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OBJECTIVES To identify intravascular sites for continuous, stable parasympathetic stimulation (PS) in
order to control the ventricular rate during atrial fibrillation (AF).
BACKGROUND Ventricular rate control during AF in patients with congestive heart failure is a significant
clinical problem because many drugs that slow the ventricular rate may depress ventricular
function and cause hypotension. Parasympathetic stimulation can exert negative dromotropic
effects without significantly affecting the ventricles.
METHODS In 22 dogs, PS was performed using rectangular stimuli (0.05 ms duration, 20 Hz) delivered
through a catheter with an expandable electrode-basket at its end. The catheter was
positioned either in the superior vena cava (SVC, n 5 6), coronary sinus (CS, n 5 10) or right
pulmonary artery (RPA, n 5 6). The basket was then expanded to obtain long-term catheter
stability. Atrial fibrillation was induced and maintained by rapid atrial pacing.
RESULTS Nonfluoroscopic (SVC) and fluoroscopic (CS/RPA) identification of effective intravascular
PS sites was achieved within 3 to 10 min. The ventricular rate slowing effect during AF
started and ceased immediately after on-offset of PS, respectively, and could be maintained
over 20 h. In the SVC, at least a 50% increase of ventricular rate (R-R) intervals occurred at
22 6 11 V (331 6 139 ms to 653 6 286 ms, p , 0.001), in the CS at 16 6 10 V (312 6
102 ms vs. 561 6 172 ms, p , 0.001) and in the RPA at 18 6 7 V (307 6 62 ms to 681 6
151 ms, p , 0.001). Parasympathetic stimulation did not change ventricular refractory
periods.
CONCLUSIONS Intravascular PS results in a significant ventricular rate slowing during AF in dogs. This may
be beneficial in patients with AF and rapid ventricular response since many drugs that
decrease atrioventricular conduction have negative inotropic effects which could worsen
concomitant congestive heart failure. (J Am Coll Cardiol 1999;34:2043–50) © 1999 by the
American College of Cardiology
Atrial fibrillation (AF) is the most common cardiac arrhyth-
mia with a prevalence of 2.3% in people older than 40 years
and 5.9% in those older than 65 years (1). Among other
cardiac and noncardiac risk factors, congestive heart failure
imposes the greatest risk of developing AF with a 4.5-fold
increased risk in men and 5.9-fold increased risk in women
(2). Moreover, in patients with overt congestive heart
failure, the prevalence of AF can rise up to 40% (3).
Ventricular rate (R-R) control during AF in patients with
congestive heart failure is a significant clinical problem. The
acute treatment of rapid ventricular response to AF requires
the administration of drugs with an immediate depressant
effect on atrioventricular (AV) conduction. However, drugs
generally used for that purpose such as beta-receptor antag-
onists and calcium-channel antagonists may also lead to
worsening of concomitant congestive heart failure and
hypotension. Amiodarone and digoxin may be used for
acute R-R control especially in patients with concomitant
congestive heart failure; yet, for both drugs there is a latency
of the onset of the negative dromotropic effect of at least
60 min (4,5).
We hypothesized that intravascular electrical stimulation
of parasympathetic cardiac nerves which innervate the AV
node might decrease the rapid ventricular response during
AF without affecting ventricular contractility. If so, a
transvenous approach to obtain stable parasympathetic
nerve stimulation might offer a new opportunity for R-R
control during AF, especially in patients with depressed
ventricular function.
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METHODS
Surgical preparations. All animal studies were approved
by the Research and Development Committee of the
Department of Veterans Affairs Medical Center, Oklahoma
City, Oklahoma. In 22 adult mongrel dogs (weight 18 to
30 kg), anesthesia was induced and maintained with intra-
venous sodium pentobarbital (30 mg/kg initial/50 to
100 mg for maintenance). The dogs were intubated and
ventilated with room air (Harvard Apparatus Co., Natick,
Massachusetts). A cannula was inserted into the left external
jugular vein for fluid and drug delivery. Blood pressure was
monitored through a cannula in the right femoral artery. A
quadripolar catheter with 2 mm interelectrode spacing was
introduced into the left carotid artery and advanced to the
aortic root to record His bundle activity. A right lateral
thoracotomy was performed at the fourth intercostal space.
After pericardiotomy pairs of plunge wire electrodes were
inserted into the right atrial appendage (RAA) and right
ventricular apex for pacing and local electrogram recording.
Electrocardiograms lead II and aVR were monitored con-
tinuously. All tracings were amplified and digitally recorded
using a computer-based Bard Labsystem (CR Bard Inc.,
Billerica, Massachusetts). Electrocardiogram filter settings
were 0.01 to 250 Hz, whereas bipolar electrograms were
filtered at 30 to 250 Hz.
Parasympathetic stimulation (PS). A 7-French basket
catheter (Cordis Webster Corp., Diamond Bar, California)
was used for PS (Fig. 1 and 2). Bipolar stimulation and
electrogram recording could be performed over adjacent pairs
of five metal electrode arms. Periods of electrical stimulation
lasting 10 s were delivered by a Grass stimulator (Astro-
Med, Inc., Grass Instruments Division, West Warwick,
Rhode Island) at a frequency of 20 Hz and a pulse duration
of 0.05 ms. These parameters had been demonstrated to be
suitable for epicardial PS while being subthreshold for
excitation of myocardium (6). The stimulation voltage,
which was delivered through a pair of splines of the basket
catheter, was monitored on an oscilloscope (Tektronix 335,
Tokyo, Japan). Parasympathetic stimulation at each of three
intravascular stimulation sites [superior vena cava (SVC),
coronary sinus (CS) and right pulmonary artery (RPA)] was
performed during AF. The latter was induced and main-
tained by constant rapid pacing at a cycle length of 100 ms
from the RAA. Once the effective CS, RPA or SVC site
Abbreviations and Acronyms
AF 5 atrial fibrillation
AV 5 atrioventricular
CS 5 coronary sinus
ERP 5 effective refractory period
PS 5 parasympathetic stimulation
RAA 5 right atrial appendage
RPA 5 right pulmonary artery
R-R 5 ventricular rate
SST 5 stimulus strength
SVC 5 superior vena cava
Figure 1. Radiogram (90° right lateral view) showing the basket
catheter at a successful cardiac nerve stimulation site in the RPA.
Panel A illustrates the catheter arrangement before the injection of
20 ml of nonionic contrast medium in the right ventricle whereas
panel B depicts the same site after injection of contrast medium.
The intravascular stimulation site was located in the proximal
RPA. In this dog, a basket catheter was also introduced into the
CS. Panel C gives a schematic explanation. CS 5 coronary sinus;
Hb 5 His bundle; LV 5 left ventricle; PA 5 pulmonary artery;
RPA 5 right pulmonary artery.
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was identified, PS was started at a stimulator output voltage
of 10 V and thereafter increased in 10 V steps to a stimulator
output voltage of 70 V (CS, equivalent to a catheter output of
16 V), 110 V (RPA, equivalent to a catheter output of 27 V)
or 150 V (SVC, equivalent to a catheter output of 39 V).
Ventricular rate intervals during PS were measured in surface
ECG leads II and aVR. At each stimulus strength (SST);
10 consecutive R-R intervals during PS were averaged.
Group 1: stimulation at the CS (n 5 10). For PS in the
CS, the catheter was introduced through the right or left
external jugular vein and advanced into the right atrium.
Positioning in the os of the CS was then performed under
fluoroscopic guidance. When the CS had been entered, the
basket was expanded to hold the catheter in a stable position
against the endovascular surface. Stimulation over each
adjacent pair of electrode arms was then attempted at a
catheter output voltage of 16 V. If no visible slowing of the
ventricular rate during AF was observed, the basket was
contracted and the catheter gently rotated or advanced
further into the CS until an effective stimulation site was
found. In three dogs, additional epicardial stimulation of
parasympathetic ganglia was performed using a handheld
bipolar stimulation electrode (electrode spacing: 5 mm).
This electrode was positioned on the fat pad at the junction
of the inferior cava and the left atrium.
Group 2: stimulation in the RPA (n 5 6). For placement
of the catheter in the RPA, the basket catheter was
introduced through a purse-string suture in the right ven-
tricular outflow tract. Under fluoroscopic control it was then
advanced into the proximal RPA. The sinus rate slowing
was assessed by stimulation over each adjacent pair of
electrode arms at a catheter output voltage of 27 V. If no
visible ventricular rate slowing during AF occurred, the
basket was contracted and withdrawn stepwise. Stimulation
was repeated until a noticeable drop in ventricular rate
during AF was achieved. Figure 1 shows a pulmonary
angiogram with the basket catheter positioned at an effective
stimulation site.
Group 3: stimulation in the SVC (n 5 6). For stimulation
in the SVC, the catheter was introduced through the right
or left external jugular vein until a right atrial electrogram
was recorded in one of the pairs of electrode arms of the
basket. The catheter was then withdrawn to an SVC site at
which no atrial signal was recorded. At this point the basket
was expanded and the ventricular rate slowing effect during
induced AF was assessed by stimulation over each adjacent
electrode pair at a catheter output voltage of 39 V. If no
slowing effect was observed, the catheter was withdrawn and
stimulation was repeated until a slowing response was
obtained. Figure 2 shows an angiographic view of the SVC
with the basket catheter positioned at a successful stimula-
tion site.
Measurement of sinus rate slowing and effective refrac-
tory period (ERP) for intravascular stimulation. In those
dogs in which stimulation was performed at the SVC and
RPA sites, we also assessed the sinus rate slowing and atrial
and ventricular effective refractory periods (ERP) and AV
conduction during PS. Successive atrium to atrium (A-A)
intervals during PS with a catheter output voltage of 39 V
(SVC) and 38 V (RPA) were measured in the RAA
electrogram. Three consecutive A-A intervals were taken
for calculation of the mean A-A interval. Atrial and ven-
Figure 2. Fluoroscopic view (90° right lateral view) of an effective
cardiac nerve stimulation site in the SVC. Panel A shows the
basket catheter, which was introduced via the right jugular vein, in
the SVC. Panel B shows the identical area after injection of 20 ml
nonionic contrast medium into the SVC through the jugular vein.
Due to the contrast medium, the basket catheter can hardly be seen
but it is obvious from Panel A that the catheter was placed just
distal to the entrance of the innominate vein from the left but
proximal to the entrance of the SVC into the RA. A schematic
view of the catheter arrangement and anatomy is shown in panel
C. RA 5 right atrium; SVC 5 superior vena cava.
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tricular ERPs were determined at baseline and during PS at
the RPA and SVC sites with a catheter output voltage of 39
V (SVC) and 38 V (RPA). The baseline ERPs and ERPs
during PS were taken after the assessment of the PS effect
on the ventricular rate during AF. For pacing and ERP
measurement, 2 ms rectangular pacing stimuli at twice the
diastolic pacing threshold were delivered by a Radionics
stimulator (Radionics, Inc., Burlington, Massachusetts) us-
ing the extrastimulus technique (basic cycle length: 400 ms,
extrastimuli: 10 ms decrements). Atrioventricular conduc-
tion was assessed by determining the cycle lengths during
incremental atrial pacing, at which anterograde second
degree AV block (Wenckebach type I) occurred.
Long-term stability of the slowing effect due to PS at the
CS, effects of atropine and section of cervical vagosym-
pathetic trunks. For evaluation of the long-term efficacy,
continuous PS was maintained at a catheter output voltage
of 25 V over 20.5 h during pacing induced AF in one dog.
Every half-hour R-R intervals during PS were measured.
The SST was then increased for 30 s to 39 V, and R-R
intervals were measured during this period. Both values
were compared with R-R intervals during a 30-s pause of
PS. In six dogs, two in each study group, 2 mg of atropine
was injected intravenously and PS was attempted again. In
three dogs, one in each study group, both cervical vagosym-
pathetic trunks were cut before PS.
Statistical analysis. All data are expressed as mean 6
standard deviation. The voltage data refer to the voltage
delivered to the heart (5 catheter output voltage) as
measured on the oscilloscope. In each group, repeated-
measure ANOVA was used to test whether the SST
affected the ventricular rate during AF. The rate slowing
effect at a given SST was compared with baseline values
without PS, applying a Wilcoxon matched pairs signed rank
test. In the dog in which a 20.5-h measurement was
performed, rate differences were compared using a Wil-
coxon matched pairs signed rank test. Refractory periods
were evaluated for significance by a Student paired t test.
Probability values #0.05 were considered significant.
RESULTS
Parasympathetic cardiac nerve stimulation in the CS.
After introduction of the basket catheter in the CS os,
identification of the CS site and the catheter splines at
which a rate slowing occurred could be achieved within
5 min. Figure 3 shows a representative example of PS in the
proximal CS. During PS at 34 6 8 V, there was a marked
increase of the R-R intervals (shortest 1,440 ms, longest
1,976 ms). Upon termination of PS (arrow), the shortest/
longest R-R intervals were 260/600 ms, respectively. The
lowest voltage at which at least a 50% increase of the R-R
intervals occurred during AF was 16 6 10 V (312 6 102 ms
without PS vs. 561 6 172 ms during PS, p , 0.001). The
effect of the applied stimulus voltage on R-R slowing was
assessed by a dose-response type curve as illustrated in
Figure 4. Stimulus strength significantly affected ventricular
rate slowing during AF (p , 0.001). The graph also shows
that direct epicardial stimulation of the parasympathetic
ganglia at the outer surface of the proximal CS required a
much lower PS voltage level. Importantly, nerve stimulation
from the epicardium during sinus rhythm with a handheld
bipolar electrode effectively prolonged the atrium to His
bundle (AH) interval without a change in the sinus rate but
was subthreshold for stimulation of atrial myocardial tissue.
By contrast, if nerve stimulation from the adjacent intravas-
cular site was performed during sinus rhythm, this excited
the atria resulting in AF at a voltage that was lower than the
one which resulted in R-R slowing during AF. Parasympa-
thetic stimulation in the CS during right ventricular pacing
at a constant cycle length of 300 ms did not significantly
affect peak systolic arterial blood pressure (121 6
Figure 3. Cardiac nerve stimulation in the CS. Surface ECG lead II, aVR and an RAA recording are depicted. Atrial fibrillation was
induced and maintained by rapid pacing from the RAA at a cycle length of 100 ms (low frequency, low amplitude pacing artifacts on the
right of the RAA tracing). Parasympathetic stimulation was done at a stimulus strength of 34 V and a frequency of 20 Hz (high frequency,
high amplitude electrical artifacts can be seen on the left of the RAA tracing). The cycle length values within the figure refer to the longest
and shortest R-R interval during AF with PS (1976 and 1440 ms, respectively) and when PS was terminated (arrow, 600 and 260 ms,
respectively). AF 5 atrial fibrillation; CS 5 coronary sinus; PS 5 parasympathetic stimulation; RAA 5 right atrial appendage; R-R 5
ventricular rate.
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10 mm Hg without PS vs. 117 6 6 mm Hg with PS; n 5
3; p 5 NS).
Parasympathetic cardiac nerve stimulation in the RPA.
Stimulation in the RPA also decreased the ventricular rate
response during AF. On average it required 10 min to
position the catheter within the RPA to find an effective
stimulation site. The effect of PS significantly depended on
the applied stimulus voltage (Fig. 4, p , 0.001). The
minimal SST inducing at least a 50% prolongation of the
R-R interval during AF required 18 6 7 V (R-R interval of
307 6 62 ms without PS vs. 681 6 151 ms with PS, p ,
0.001). This rate slowing effect was probably due to a
negative dromotropic effect of PS on the AV node as
indicated by a prolongation of the anterograde Wenckebach
cycle length from 257 6 40 ms without PS to 384 6 39 ms
with PS in the RPA (p 5 0.01, n 5 5). Stimulation in the
RPA also produced a shortening of the right atrial refractory
period (136 6 13 ms without PS vs. 96 6 22 ms during PS,
n 5 5, p 5 0.03) whereas the right ventricular refractory
period did not change significantly with PS (184 6 25 ms
with PS vs. 186 6 26 without PS, n 5 5). Moreover, a
significant slowing of the sinus rate was observed during PS
(1,181 6 306 ms during PS vs. 518 6 138 ms without PS,
n 5 6, p 5 0.01). Parasympathetic stimulation in the RPA
during right ventricular pacing at a constant cycle length of
300 ms did not significantly change peak systolic arterial
blood pressure (115 6 13 mm Hg without PS vs. 113 6
9 mm Hg with PS; n 5 3; p 5 NS).
Parasympathetic cardiac nerve stimulation in the SVC.
Positioning of the basket catheter at an effective nerve
stimulation site in the SVC was achieved within 3 min, after
the introduction of the basket catheter through the jugular
vein. A typical example of ventricular rate slowing during
PS is shown in Figure 5. The lowest voltage at which a 50%
increase of the mean ventricular cycle length during AF
occurred was 22 6 11 V (331 6 139 ms without PS vs.
653 6 286 ms during PS, p , 0.001). The SST during PS
significantly affected the R-R during AF as illustrated in
Figure 4 (p , 0.001). Parasympathetic stimulus in the SVC
exerted a negative dromotropic effect on the AV node: the
anterograde Wenckebach cycle length increased from 263 6
107 ms without PS to 391 6 66 ms with PS in the SVC
(p , 0.01, n 5 5). During sinus rhythm, PS led to a
significant increase in the average sinus cycle length (489 6
154 ms without PS vs. 1,056 6 355 ms with PS, n 5 6, p ,
0.001) and to a shortening of the right atrial refractory
period (145 6 55 ms without PS vs. 78 6 71 ms with PS,
n 5 6, p 5 0.03). The right ventricular refractory period did
not change significantly during PS (172 6 26 ms with PS
vs. 176 6 34 ms without PS, n 5 5). In addition, PS in the
SVC did not significantly change peak systolic arterial blood
pressure during right ventricular pacing at a constant cycle
length of 300 ms (105 6 14 mm Hg without PS vs. 110 6
19 mm Hg with PS; n 5 3; p 5 NS). Intermittent
stimulation of the phrenic nerve was sometimes observed
during stimulation across various splines of the basket
catheter. When the site and electrode pair was found at
which electrical stimulation induced ventricular slowing
during AF, stimulation of the phrenic nerve was never
observed.
Long-term stability of the slowing effect due to PS at the
CS, effects of atropine and section of cervical vagosym-
pathetic trunks. Continuous PS in the CS was performed
over 2 h in two dogs. Although the mean R-R interval
during AF after 2 h of PS was shorter than at the onset of
PS (644 6 149 ms vs. 778 6 210 ms, respectively, n 5 2),
it was still longer compared with the R-R intervals without
PS (452 6 114 ms, n 5 2). In another dog, the stability of
the rate slowing effect was assessed over a 20.5-h period as
illustrated in Figure 6. The effect of R-R slowing during AF
slightly diminished in the first 3 h of PS but then remained
fairly constant. After 20.5 h there was still a considerable
decrease of the R-R during PS as compared with no PS.
The latter was determined during a 30 s period of no PS. Of
note, this small loss of efficacy over 20.5 h was overcome if
the PS voltage was increased from 25 to 39 V as shown in
Figure 6. At all three stimulation sites, the effect of PS on
the ventricular response during AF was completely abol-
Figure 4. Effect of SST on R-R slowing during PS in the CS,
RPA, and SVC. Average R-R intervals during AF are plotted
versus the SST. The SST significantly affected the R-R interval
during AF at all three intravascular sites (p , 0.001 each,
ANOVA). The mean R-R interval at each SST was also compared
with the R-R interval without PS (*p , 0.05). Of note, during
epicardial PS at the CS ostium, the threshold for a ventricular
slowing effect during AF was considerably lower than during
endovascular PS in the CS. AF 5 atrial fibrillation; ANOVA 5
analysis of variance; CS 5 coronary sinus; PS 5 parasympathetic
stimulation; RPA 5 right pulmonary artery; R-R 5 ventricular
rate; SST 5 stimulus strength.
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Figure 5. Cardiac nerve stimulation (PS) in the SVC. Surface ECG leads I, II and aVF and a recording of the stimuli (stim) delivered
to the basket catheter are depicted. Atrial fibrillation was induced and maintained by rapid pacing from the RAA at a cycle length of
100 ms (low frequency, low amplitude electrical artifacts). A vertical arrow in both panels indicates the onset of PS. At a PS intensity
of 13 V, the shortest R-R interval during AF prolonged from 352 ms to 384 ms and the longest R-R interval from 408 to 1464 ms (panel
A). Increasing the stimulus amplitude to 22 V led to an even greater increase of the R-R intervals (shortest: 272 ms to 1,008 ms; longest:
380 ms to 2,336 ms) as illustrated in panel B. AF 5 atrial fibrillation; PS 5 parasympathetic stimulation; RAA 5 right atrial appendage;
R-R 5 ventricular rate; stim 5 stimuli; SVC 5 superior vena cava.
Figure 6. Continuous parasympathetic cardiac nerve stimulation in the coronary sinus over 20.5 h. The R-R interval during AF is plotted
versus time (see text for discussion). AF 5 atrial fibrillation; R-R interval 5 ventricular rate.
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ished after intravenous injection of 2 mg of atropine.
Cutting of both cervical vagosympathetic trunks did not
prevent the PS related decrease of the ventricular response
during AF at any of the three stimulation sites indicating
that probably stimulation of efferent nerves was responsible
for the rate decrease.
Effect of different impulse durations. The influence of
different pulse durations of the electrical stimuli during PS
in the SVC was evaluated in one dog. Nerve stimulation was
performed in the SVC at 32 V, 20 Hz. Maximal rate
slowing was observed at an impulse duration of 2 ms
(626 ms) as compared with 341 ms at 0.05 ms and 262 ms
without PS. Thus, the optimal impulse duration (2 ms) was
considerably longer than the one applied in this study
(0.05 ms).
DISCUSSION
In this study we described a transvenous approach for
consistent and stable parasympathetic cardiac nerve stimu-
lation in dogs at three distinctive intravascular anatomical
sites. Our findings corroborate and extend the various
epicardial (6–10) and endocardial (11,12) approaches de-
scribed previously.
Epicardial stimulation of parasympathetic ganglia located
in a fat pad near the proximal CS has been reported to affect
AV nodal conduction but not to affect the sinus rate or the
atrial refractory period (6,7). Likewise, Ali et al. (8) reported
recently that epicardial stimulation at the proximal CS
resulted in R-R slowing during atrial tachycardias and AF,
which was prevented by atropine. Similarly, intravascular PS
in the proximal CS caused a considerable R-R slowing
during AF in this study which was completely abolished
after atropine injection.
Extracardiac stimulation of a fat pad which contained
parasympathetic ganglia and was located adjacent to the
RPA was reported to result in mixed responses such as
prolongation of AV conduction, sinus rate slowing and
shortening of the atrial refractory period (9). The same
observations were made in this study, when intravascular
stimulation at the RPA site was performed, suggesting that
similar structures have been stimulated in both studies.
These three electrophysiological effects can also be
achieved during intravascular stimulation of cardiac nerves
in the SVC as shown in this study. Negative dromotropic
and chronotropic effects were also found by Armour et al.
(10) during external stimulation of mediastinal cardiac
nerves in open-chest dogs. However, besides slowing of the
sinus rate and a prolongation of AV nodal conduction,
stimulation of some nerves induced an increase of the
supraventricular rate. The same group recently observed a
sinus rate slowing during transvenous electrical stimulation
of parasympathetic nerves in the right internal jugular vein
or SVC using conventional electrode catheters in animals
(11). In that study exact positioning of a conventional
electrode catheter under fluoroscopy was crucial to obtain a
sinus slowing. A significant advantage of a basket catheter as
compared with a conventional electrode catheter is the ease
of identification of an effective stimulation site and the
stability of the catheter position at this site in the vessel over
20 h. Moreover, stimulation in the SVC with a basket
catheter does not require fluoroscopy, which makes it
particularly suitable for the acute treatment of rapidly
conducting AF in critically ill patients.
To be of clinical value it is important to know whether
the negative dromotropic effects can be maintained over a
longer stimulation period. The results of our study indicate
that at least for a stimulation period of 20.5 h the negative
dromotropic effect in the CS can be maintained. This is
noteworthy because a fade of the response during short-
term PS has been reported for the negative chronotropic
effect and the negative inotropic effect on the atria (13). By
contrast, a decrease of the negative dromotropic response
was not observed in one study (14) whereas another study
reported either no decrease, an augmentation or a small fade
of the negative dromotropic response during a 5 min
stimulation period (15). Possible mechanisms for a fade of
the parasympathetic response were elaborately discussed by
Salata and Jalife (16).
Clinical implications. Clinical application of the proposed
approaches to intravascular PS requires the demonstration
of similar anatomical cardiac nerve distributions and elec-
trophysiological effects with nerve and ganglia stimulation
in humans. There is evidence from recent histological
studies that a large population of neural ganglia is present at
the ostium of the CS and adjacent to the base of the
pulmonary artery and aortic root in humans (17). More
recently Chen et al. (12) were able to demonstrate intracar-
diac PS from the endocardial surface at the posteroseptal
area of the right atrium in humans using a 4 mm tip
deflectable catheter. This demonstration was made in order
to confirm that slow pathway ablation which terminates AV
reentrant tachycardia did not also denervate the parasym-
pathetic input to the AV node. Thoracic cardiac nerve
stimulation has been attempted in patients during coronary
artery bypass operations (18). It was found that nerve
excitation resulted in sinus rate slowing in some patients but
led to an increase in heart rate in others. However, the study
was performed during sinus rhythm and without the use of
His bundle recordings. Therefore, if present, negative
dromotropic effects might not have been recognized.
The stimulation method presented in this study might
have several advantages as compared with the conventional
treatment for AF with rapid ventricular response. First,
intravascular PS decreases the R-R during AF without
exerting significant negative inotropic effects on the ventri-
cles. Thus, these approaches avoid the ventricular negative
inotropic effects of many pharmacological agents that are
currently used to slow AV conduction during AF, such as
calcium channel antagonists and beta-adrenergic blocking
agents. The proposed single catheter approach may, there-
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fore, be used in circumstances in which AF with rapid
ventricular response worsens coexisting congestive heart
failure, which is a situation most commonly seen in critically
ill patients.
Second, the on- and offset of the rate slowing effect
occurred promptly after initiation and termination of PS,
respectively. Moreover, by changing the applied stimulus
voltage, the effect of rate slowing may be titrated to the
specific demands in patients with dynamically changing
medical conditions. By contrast, drugs—once given—
exhibit their effects and side-effects depending on their
half-life which is, except for the short acting agents such as
esmolol, in the range of hours. Therefore, changes in the
patients’ medical conditions, particularly development of or
worsening of congestive heart failure, may require admin-
istration of counteracting pharmacological agents, i.e., cat-
echolamines. This, in turn may increase the R-R during AF.
Third, in patients in whom unstable hemodynamics
develop during rapidly conducting AF, intubation and
cardioversion may be required. Transvenous PS may obviate
the need for emergency intubation and cardioversion and its
associated complications.
Study limitations. Parasympathetic stimulation at the CS
site resulted in electrical excitation of atrial tissue. Although
this may not be relevant in the setting of chronic AF, it may
contribute to the perpetuation of AF in patients with recent
onset AF. The use of SVC and RPA sites can provide the
desired effect without atrial stimulation.
A second issue that needs to be addressed might be blood
clotting within the basket. Because our dogs were heparin-
ized, we did not observe clotting in the present experiment.
Because many patients with AF receive either oral or
intravenous anticoagulation, clotting within the CS might
not occur in patients either. However, we cannot exclude
that, without anticoagulation, formation of coagula within
the basket or in the distal CS may occur.
Stimulation at the RPA and SVC site resulted in a
shortening of the right atrial refractory period. We cannot
rule out that this may contribute to the perpetuation of AF
in patients with recent onset AF. Apart from this, a
shortening of the atrial refractory periods during PS could
have caused an increased atrial rate during AF, which in part
may have contributed to the slowing of the R-R during PS.
However, the findings of a significant prolongation of the
anterograde Wenckebach cycle length during PS in the
SVC and RPA are a strong evidence for a direct interference
of PS with conduction in the AV node.
Finally, it also cannot be excluded that PS in the SVC
may excite nerve fibers that provide the bronchiopulmonary
system or the gut, possibly resulting in coughing, vomiting
or chest discomfort in the unanesthetized state.
Conclusions. Cardiac parasympathetic nerves that project
to the AV node can be stimulated intravascularly with a
basket catheter in dogs. Three intravascular sites at which a
substantial reduction in R-R during AF can be obtained
were identified: the SVC, the ostium of the CS and the
RPA. By changing the stimulation voltage, a graded re-
sponse of the R-R during AF ranging from slight slowing to
complete AV block was observed. If these findings translate
to patients, PS may be beneficial in AF patients with rapid
ventricular response and poor ventricular function in whom
rate control with drugs could exacerbate already compro-
mised ventricular contractility.
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